CJC 1295 with DAC

CJC-1295 with DAC is a synthetic variant of growth hormone-releasing hormone and is a performance peptide hormone that increases both the production of growth hormone and IGF-1 in healthy adult subjects.

A single injection in human subjects increases plasma growth hormone levels by up to tenfold for six days and plasma IGF-1 levels by up to threefold for eleven days.

Because of its long half-life in humans, it remains active for longer periods of time and increases the bioavailability of growth hormone-releasing hormone.

In addition to this, CJC-1295 with DAC breaks down fat tissue, boosts injury recovery, and enhances bone density.

It has also been purported to reduce aging factors such as skin wrinkles and improve skin quality. This makes sense because peptide was initially being developed for the treatment of lipodystrophy and growth hormone deficiency and reached phase II clinical trials. It acts to help distribute fat deposits and adipose tissue which has a drastic impact on skin look and texture.

CJC-1295 is sold in vials containing 2MG of lyophilised powder which can be reconstituted by adding a convenient amount of sterile or bacteriostatic water.

Dosage:

CJC-1295 is sold in vials containing 2MG of lyophilised powder which should be stored under refrigeration. (It is acceptable however for them to be mailed unrefrigerated.)

Note: All compounds are high quality, and are for research purposes only. No statements made on this site or blog have been evaluated by the FDA or any international equivalent. These products are not intended to treat, cure or prevent any disease or illness. All products are strictly for research purposes only. Please refer to our product use and disclaimer for more information.